Effect of AF, olaparib and aurola treatment on immune-related

An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic

Christophe DEBEN, PostDoc Position, PhD

PDF) Auranofin Synergizes with the PARP Inhibitor Olaparib to

beta Actin Polyclonal Antibody (20536-1-AP)

Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions, Journal of Translational Medicine

Revealing the selective mechanisms of inhibitors to PARP-1 and PARP-2 via multiple computational methods [PeerJ]

Frontiers Toxicities of Immunotherapy for Small Cell Lung Cancer

Potential Therapeutic Targets in Ovarian Cancer: Autophagy and Metabolism

Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited - ScienceDirect

Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review - ScienceDirect

Effect of AF, olaparib and aurola treatment on immune-related

The intracellular gold concentration levels caused by the

From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer, Journal of Ovarian Research